[go: up one dir, main page]

AU2001271058A1 - Method for producing 1-substituted-1,2,3-triazole derivative - Google Patents

Method for producing 1-substituted-1,2,3-triazole derivative

Info

Publication number
AU2001271058A1
AU2001271058A1 AU2001271058A AU7105801A AU2001271058A1 AU 2001271058 A1 AU2001271058 A1 AU 2001271058A1 AU 2001271058 A AU2001271058 A AU 2001271058A AU 7105801 A AU7105801 A AU 7105801A AU 2001271058 A1 AU2001271058 A1 AU 2001271058A1
Authority
AU
Australia
Prior art keywords
substituted
producing
triazole derivative
triazole
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001271058A
Other languages
English (en)
Inventor
Tomomi Ikemoto
Yasushi Isogami
Tatsuya Ito
Hirohiko Nishiyama
Yasuhiro Sawai
Kiminori Tomimatsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU2001271058A1 publication Critical patent/AU2001271058A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2001271058A 2000-07-19 2001-07-16 Method for producing 1-substituted-1,2,3-triazole derivative Abandoned AU2001271058A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
JP2000218834 2000-07-19
JP2000-218814 2000-07-19
JP2000-218834 2000-07-19
JP2000218814 2000-07-19
JP2000284925 2000-09-20
JP2000-284925 2000-09-20
JP2001-160464 2001-05-29
JP2001160464 2001-05-29
PCT/JP2001/006145 WO2002006249A1 (fr) 2000-07-19 2001-07-16 Procede de fabrication d'un derive de 1,2,3 triasol substitue en position 1

Publications (1)

Publication Number Publication Date
AU2001271058A1 true AU2001271058A1 (en) 2002-01-30

Family

ID=27481467

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001271058A Abandoned AU2001271058A1 (en) 2000-07-19 2001-07-16 Method for producing 1-substituted-1,2,3-triazole derivative

Country Status (6)

Country Link
US (2) US6743924B2 (fr)
EP (1) EP1310491A1 (fr)
KR (3) KR20040101564A (fr)
AU (1) AU2001271058A1 (fr)
CA (1) CA2415961A1 (fr)
WO (1) WO2002006249A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003031442A1 (fr) * 2001-10-05 2003-04-17 Takeda Chemical Industries, Ltd. Composes heterocycliques, derives oxazole, procede permettant de les presenter et leur utilisation
US7247649B2 (en) * 2003-08-13 2007-07-24 Hoffmann-La Roche Inc. Oxazoles, their manufacture and use as pharmaceutical agents
CA2561206A1 (fr) * 2004-04-02 2005-10-20 F. Hoffmann-La Roche Ag Derives de diazine, fabrication et utilisation de ceux-ci comme agents pharmaceutiques
US20060116407A1 (en) * 2004-11-22 2006-06-01 Birgit Bossenmaier Amide derivatives
US7429605B2 (en) * 2005-08-04 2008-09-30 Hoffmann-La Roche Inc. Phenylpyridine derivatives
WO2007128463A1 (fr) * 2006-05-02 2007-11-15 Dsm Ip Assets B.V. Procede de deprotection d'amines protegees
WO2010068287A2 (fr) * 2008-12-11 2010-06-17 Angion Biomedica Corp. Modulateurs à petites molécules de l'activité du facteur de croissance (facteur de dispersion) des hépatocytes
WO2010104837A1 (fr) * 2009-03-11 2010-09-16 Isp Investments Inc. Régioisomères de 1,2,3-triazoles à substitution vinyle en 4 et 5 fonctionnalisés par cycloaddition 1,3-dipolaire et leurs polymères
CN103159748B (zh) * 2011-12-19 2016-12-21 天津市国际生物医药联合研究院 2-(1h-1，2，3-三氮唑-4-基)苯胺类化合物的制备和用途
KR102496364B1 (ko) 2014-09-10 2023-02-06 에피자임, 인코포레이티드 Ｓｍｙｄ 억제제
CN111961006B (zh) * 2020-07-31 2023-03-28 同济大学 一种木利替尼三氮唑中间体的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05170763A (ja) * 1991-06-10 1993-07-09 Sankyo Co Ltd ２−置換オキセタン誘導体
JPH0853425A (ja) * 1994-08-10 1996-02-27 Otsuka Chem Co Ltd １，２，３−トリアゾール誘導体の製造法
ATE338754T1 (de) * 1996-07-19 2006-09-15 Takeda Pharmaceutical Heterocyclische verbindungen, ihre herstellung und verwendung
PE20011178A1 (es) * 2000-04-07 2001-11-19 Takeda Chemical Industries Ltd Compuestos heterociclicos y su produccion

Also Published As

Publication number Publication date
US20040106803A1 (en) 2004-06-03
EP1310491A1 (fr) 2003-05-14
WO2002006249A1 (fr) 2002-01-24
KR20040101564A (ko) 2004-12-02
KR20050063747A (ko) 2005-06-28
CA2415961A1 (fr) 2002-01-24
KR20030013360A (ko) 2003-02-14
US6743924B2 (en) 2004-06-01
US20030069419A1 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
AU3073400A (en) Method for producing chlorine
AU2002218319A1 (en) Method for producing 1,2-dichloroethane
AU2000230735A1 (en) Method for producing chlorine
AU2002230470A1 (en) Process for preparing pouches
AU2001239243A1 (en) Method for producing nanosuspensions
AU2001263004A1 (en) System for continuously producing gum
AU2001291882A1 (en) Method for producing polyisobutylphenols
AU2001278423A1 (en) Method for producing aldehydes
AU2002210535A1 (en) Method for producing melamine
AU2001271058A1 (en) Method for producing 1-substituted-1,2,3-triazole derivative
AU2002218171A1 (en) Method for producing aryl compounds
AU3734301A (en) Method for producing 2-chloro-benzimidazole derivatives
AU2001269505A1 (en) Fumarate derivative, method for producing the same
AU5214300A (en) Method for producing 2,2,4,4-tetra-substituted 1,3,5-cyclohexanetriones
AU2002212224A1 (en) Method for producing delta1-pyrrolines
AU2001260605A1 (en) Process for producing antioxidant
AU2001235423A1 (en) Method for producing 2,3,5,6-tetrahalogen-xylylidene compounds
AU2001262147A1 (en) Method for producing 4-bromo- and 4-chloro-2-nitro-1-trifluoromethoxybenzene
AU2002227980A1 (en) Method for producing 1-(2,2,6-trimethylcyclohexyl)-3-alkanols
AU1141501A (en) Method for producing hydroxymethylpyridines
AU1283001A (en) Method for producing alkylhalogenosilanes
AU6864100A (en) Method for producing 2,6-dimethylnaphthalene
AU2001284442A1 (en) Process for producing fluoroalkanol
AU6691600A (en) Method for producing 4-cyano-2-aminomethylthiazol
AU2001287723A1 (en) Method for producing delta 1-pyrrolines